Tumor markers are associated with rapidly progressive interstitial lung disease in adult-dermatomyositis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tumor markers are associated with rapidly progressive interstitial lung disease in adult-dermatomyositis

Published:2022-02-09 Issue:6 Volume:41 Page:1731-1739
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Wang Qianqian,Gao Congcong,Zhang Chunyi,Yao Menghui,Liang Wenfang,Sun Wenbo,Zheng Zhaohui^ORCID

Funder

The Research Project of Medical Science and Technology of Henan Province of China

The Key Specialized Research and Development Program of Henan

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

https://link.springer.com/content/pdf/10.1007/s10067-022-06089-z.pdf

Reference40 articles.

1. Smoyer-Tomic KE, Amato AA, Fernandes AW (2012) Incidence and prevalence of idiopathic inflammatory myopathies among commercially insured, Medicare supplemental insured, and Medicaid enrolled populations: an administrative claims analysis. BMC Musculoskelet Disord 13:103. https://doi.org/10.1186/1471-2474-13-103

2. Robinson AB, Reed AM (2011) Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis. Nat Rev Rheumatol 7(11):664–675. https://doi.org/10.1038/nrrheum.2011.139

3. Lundberg IE, Tjarnlund A, Bottai M, Werth VP, Pilkington C, Visser M et al (2017) 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis 76(12):1955–1964. https://doi.org/10.1136/annrheumdis-2017-211468

4. Bowerman K, Pearson DR, Okawa J, Werth VP (2020) Malignancy in dermatomyositis: A retrospective study of 201 patients seen at the University of Pennsylvania. J Am Acad Dermatol 83(1):117–122. https://doi.org/10.1016/j.jaad.2020.02.061

5. Sugiyama Y, Yoshimi R, Tamura M, Takeno M, Kunishita Y, Kishimoto D et al (2018) The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease. Arthritis Res Ther 20(1):7. https://doi.org/10.1186/s13075-017-1506-7

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the efficacy of haemoperfusion for dermatomyositis-associated acute exacerbation of interstitial lung disease: A multicentre retrospective study;Modern Rheumatology;2024-08-08

2. Predicting the risk of interstitial lung disease in patients with primary Sjögren's syndrome: Novel nomogram and elevated Th2 cells;Molecular Immunology;2024-04

3. Clinical and immunological characteristics and prognosis of patients with autoantibody negative dermatomyositis: a case control study;Clinical Rheumatology;2024-02-07

4. Prognostic value of serum oncomarkers for patients hospitalized with acute exacerbation of interstitial lung disease;Therapeutic Advances in Respiratory Disease;2024-01

5. Association of serum tumor markers with serous effusion in systemic lupus erythematosus;Heliyon;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3